Twist Bioscience Corporation is a synthetic biology company. The Company is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. Its silicon-based DNA writing platform offers synthesis of genes on silicon. Its products include clonal perfect genes and non-clonal fragments. It offers protein scanning single variant libraries. Its design methodology, coupled with its silicon-based synthesis platform, enables synthesis of each library variant positioned exactly where user wants it to be. It offers unamplified oligo pools and cloning-ready oligo pools. Its platform offers synthesis of oligonucleotide pools for specific targeting.
https://www.twistbioscience.com/© 2026 J2T Services Ltd
J2T Services Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by J2T SERVICES LTD.
Registration Number: HE 341520
Address: J2T Services Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
E-mail: 24_support@j2t.com
